최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0420535 (2003-04-21) |
등록번호 | US-7258693 (2007-08-21) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 109 인용 특허 : 630 |
A method of penetrating tissue is provided. The method comprises using a lancet driver to advance a lancet into the tissue; advancing the lancet at a first desired velocity in a first layer of tissue; advancing the lancet at a second desired velocity in a second layer of tissue; and advancing the la
A method of penetrating tissue is provided. The method comprises using a lancet driver to advance a lancet into the tissue; advancing the lancet at a first desired velocity in a first layer of tissue; advancing the lancet at a second desired velocity in a second layer of tissue; and advancing the lancet at a third desired velocity in a third layer of tissue. In one embodiment, the method may including using a processor having logic for controlling velocity of the lancet in each layer of tissue.
What is claimed is: 1. A method of penetrating tissue comprising: using a lancet driver to advance a lancet into said tissue; advancing said lancet at a first desired velocity in a first layer of tissue; advancing said lancet at a second desired velocity in a second layer of tissue; advancing said
What is claimed is: 1. A method of penetrating tissue comprising: using a lancet driver to advance a lancet into said tissue; advancing said lancet at a first desired velocity in a first layer of tissue; advancing said lancet at a second desired velocity in a second layer of tissue; advancing said lancet at a third desired velocity in a third layer of tissue; and creating a wound in the tissue; wherein at least two of the first, the second, the third velocity being different; and wherein the first, the second and the third layer are different tissue layer. 2. The method of claim 1 further comprising using a processor having logic for controlling velocity of the lancet in each layer of tissue. 3. The method of claim 2 wherein said lancet achieves a lancet velocity between about 4 to 10 m/s while in at least one of the layers of tissue. 4. The method of claim 2 wherein said lancet achieves a penetration depth, as measured from a surface of the tissue, of between about 0.5 to about 2.0 mm. 5. The method of claim 2 wherein said second desired velocity is sufficient to minimize nerve stimulation while maintaining cutting efficiency. 6. The method of claim 2 wherein said second velocity is the same as the first velocity. 7. The method of claim 2 wherein said first velocity is at least partially determined based on hydration of the stratum corneum. 8. The method of claim 2 wherein said second velocity is at least partially determined based on hydration of the stratum corneum. 9. The method of claim 2 wherein a four edge algorithm is used to control lancet velocity. 10. The method of claim 2 wherein there are at least 30 different decision points to change lancet velocity during penetration. 11. The method of claim 2 wherein there are at least 30 different decision points to change lancet velocity prior to the lancet reaching a stopped position in the tissue. 12. The method of claim 2 further comprising using a first detection algorithm on a lancet inbound phase and a second detection algorithm on a lancet outbound phase. 13. The method of claim 2 controlling lancet velocity to within 1% at a speed of 5 m/s. 14. The method of claim 2 lancing according to regional velocity profiles based on variation of cell type. 15. The method of claim 2 lancing according to regional velocity, said velocity base on changes of regional cell types and the resistance they provide. 16. The method of claim 2 lancing according to regional velocity profiles based on location to pain sensors. 17. The method of claim 2 wherein position and velocity are determined based on cell population and distribution in the different zones of tissue. 18. The method of claim 2 wherein said lancet has a maximum velocity through a stratum corneum, has a velocity in the epidermis sufficient to reduce shock waves to pain sensor in dermis, and a velocity through in the dermis sufficient for efficient cutting of blood vessels without stimulating pain sensors. 19. The method of claim 1 wherein said penetrating member achieves a penetrating member velocity between about 4 to 10 m/s while in at least one of the layers of tissue. 20. The method of claim 1 wherein said penetrating member achieves a penetration depth, as measured from a surface of the tissue, of between about 0.5 to about 2.0 mm. 21. The method of claim 1 wherein said penetrating member is sufficient to minimize nerve stimulation while maintaining cutting efficiency. 22. The method of claim 1 wherein said second velocity is the same as the first velocity. 23. The method of claim 1 wherein said first velocity is at least partially determined based on hydration of the stratum corneum. 24. The method of claim 1 wherein said second velocity is at least partially determined based on hydration of the stratum corneum. 25. The method of claim 1 wherein a four edge algorithm is used to control penetrating member velocity. 26. The method of claim 1 wherein there are at least 30 different decision points to change penetrating member velocity during penetration. 27. The method of claim 1 wherein there are at least 30 different decision points to change penetrating member velocity prior to reaching. 28. The method of claim 1 further comprising using a first detection algorithm on a penetrating member inbound phase and a second detection algorithm on a penetrating member outbound phase. 29. The method of claim 1 controlling penetrating member velocity to within 1% at a speed of 5 m/s. 30. The method of claim 1 lancing according to regional velocity profiles based on variation of cell type. 31. The method of claim 1 lancing according to regional velocity, said velocity based on changes of regional cell types and the resistance they provide. 32. The method of claim 1 lancing according to regional velocity profiles based on location to pain sensors. 33. The method of claim 1 wherein position and velocity are determined based on cell population and distribution in the different zones of tissue. 34. The method of claim 1 wherein said penetrating member has a maximum velocity through a stratum corneum, has a velocity in the epidermis sufficient to reduce shock waves to pain sensor in dermis, and a velocity through in the dermis sufficient for efficient cutting of blood vessels without stimulating pain sensors.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.